Literature DB >> 12324250

The bacterial ribosome, a promising focus for structure-based drug design.

David J C Knowles1, Nicolas Foloppe, Natalia B Matassova, Alastair I H Murchie.   

Abstract

Recent crystal structures of the bacterial ribosome have identified the complex molecular interactions involved in antibiotic-ribosome recognition. Insights into the binding of aminoglycosides, macrolides, tetracyclines and other antibiotics provide opportunities for computational, structure-based approaches to be used in the design of appropriate modifications to existing antibiotics as well as in the discovery of completely new drug classes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12324250     DOI: 10.1016/s1471-4892(02)00205-9

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  14 in total

1.  Validation of an empirical RNA-ligand scoring function for fast flexible docking using Ribodock.

Authors:  S David Morley; Mohammad Afshar
Journal:  J Comput Aided Mol Des       Date:  2004-03       Impact factor: 3.686

2.  Nucleotide modifications and tRNA anticodon-mRNA codon interactions on the ribosome.

Authors:  Olof Allnér; Lennart Nilsson
Journal:  RNA       Date:  2011-10-25       Impact factor: 4.942

3.  Integron-Derived Aminoglycoside-Sensing Riboswitches Control Aminoglycoside Acetyltransferase Resistance Gene Expression.

Authors:  Shasha Wang; Weizhi He; Wenxia Sun; Jun Zhang; Yaowen Chang; Dongrong Chen; Alastair I H Murchie
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

4.  Fluorescent pyrimidine ribonucleotide: synthesis, enzymatic incorporation, and utilization.

Authors:  Seergazhi G Srivatsan; Yitzhak Tor
Journal:  J Am Chem Soc       Date:  2007-01-26       Impact factor: 15.419

5.  Structure-guided discovery of novel aminoglycoside mimetics as antibacterial translation inhibitors.

Authors:  Yuefen Zhou; Vlad E Gregor; Zhongxiang Sun; Benjamin K Ayida; Geoffrey C Winters; Douglas Murphy; Klaus B Simonsen; Dionisios Vourloumis; Sarah Fish; Jamie M Froelich; Daniel Wall; Thomas Hermann
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

6.  Discovery and Analysis of Natural-Product Compounds Inhibiting Protein Synthesis in Pseudomonas aeruginosa.

Authors:  Yanmei Hu; Megan Keniry; Stephanie O Palmer; James M Bullard
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

7.  Novel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathways.

Authors:  Jérôme Mulhbacher; Eric Brouillette; Marianne Allard; Louis-Charles Fortier; François Malouin; Daniel A Lafontaine
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

8.  Novel antibacterial class.

Authors:  Peter J Dandliker; Steve D Pratt; Angela M Nilius; Candace Black-Schaefer; Xiaoan Ruan; Danli L Towne; Richard F Clark; Erika E Englund; Rolf Wagner; Moshe Weitzberg; Linda E Chovan; Robert K Hickman; Melissa M Daly; Stephan Kakavas; Ping Zhong; Zhensheng Cao; Caroline A David; Xiaoling Xuei; Claude G Lerner; Niru B Soni; Mai Bui; Linus L Shen; Yingna Cai; Philip J Merta; Anne Y C Saiki; Bruce A Beutel
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

9.  Search for novel aminoglycosides by combining fragment-based virtual screening and 3D-QSAR scoring.

Authors:  Piotr Setny; Joanna Trylska
Journal:  J Chem Inf Model       Date:  2009-02       Impact factor: 4.956

10.  Persister Development by Borrelia burgdorferi Populations In Vitro.

Authors:  John R Caskey; Monica E Embers
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.